NCT07767175 · Novo Nordisk A/S
A First-in-human Research Study on How NNC0721-8060 Works in People Living With Overweight or Obesity
What this study is about
The purpose of the study is to find out if NNC0721-8060 is safe and how it works in people living with overweight or obesity.
View original scientific description
The purpose of the study is to find out if NNC0721-8060 is safe and how it works in people living with overweight or obesity.
Interventions
DRUG
NNC0721-8060
NNC0721-8060 will be administered subcutaneously.
DRUG
Semaglutide
Semaglutide will be administered subcutaneously.
DRUG
Placebo
Placebo will be administered subcutaneously.
Primary outcome measures
Part A: Number of treatment emergent adverse events (TEAE)
Time frame: From Day 1 to Day 36
Measured as number of events.
Part B: Number of treatment emergent adverse events (TEAE)
Time frame: From Day 1 to Day 57
Measured as number of events.
Part C: Change from baseline in body weight
Time frame: From Day 1 to Day 85
Measured as percentage change in body weight.
Who can participate
This study lists these criteria on ClinicalTrials.gov. A study coordinator reviews eligibility during screening — this page does not determine whether you qualify.
Inclusion criteria
- Male or female (sex at birth).
- Age 18-55 years (both inclusive) at the time of signing informed consent.
- Body Mass Index (BMI) 27.0-34.9 kilograms per square metre (kg/m\^2) (both inclusive) at screening, with overweight due to excess adipose tissue as judged by the investigator.
- Considered eligible based on medical history, physical examination, vital signs, electrocardiogram and clinical laboratory tests at screening, as judged by the investigator.
Exclusion criteria
- Known or suspected hypersensitivity to study intervention(s) or related products.
- Previous randomisation in this study.
- History of allergies (with the exception of seasonal allergies) or history of anaphylactic reactions.
- Female who is pregnant, breastfeeding, intends to become pregnant, or is of childbearing potential and not using adequate contraception.
- Current participation (signed informed consent) in any other interventional clinical study.
- Exposure to an investigational medicinal product within 30 days or five half-lives of that product (whichever is longer) before screening.
- Any disorder, unwillingness or inability which, in the investigator's opinion, might jeopardise participant safety or compliance with the protocol.
- Glycated haemoglobin (HbA1c) greater than or equal to (≥) 6.5 percentage (%) (48 millimoles per mole \[mmol/mol\]) at screening.
Where
- Lenexa, Kansas
- San Antonio, Texas
Related conditions & keywords
Frequently asked questions
What is a clinical trial?
A clinical trial is a research study that tests new medical treatments, drugs, devices, or procedures to determine their safety and effectiveness. Trials are carefully designed and monitored to protect participants while advancing medical knowledge.
Is it safe to participate?
Clinical trials follow strict safety guidelines and ethical standards. Trials must be reviewed and approved, and participants are closely monitored by medical professionals throughout the study. You can withdraw at any time if you choose.
Will I be compensated?
Many clinical trials offer compensation for your time, travel expenses, and inconvenience. The specific compensation varies by study and will be discussed during the screening process. All study-related medical care is typically provided at no cost to participants.
Will I receive a placebo instead of treatment?
When effective treatment exists, participants typically receive either the standard treatment plus the study intervention, or the standard treatment plus placebo. You would not be denied effective care. Placebos are primarily used when no proven treatment is available, or in addition to standard care. Your trial consent form will clearly explain what treatments you may receive.
Can I leave a trial if I change my mind?
Absolutely. Participation in clinical trials is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty or loss of benefits to which you are otherwise entitled.
How long does a clinical trial last?
Trial duration varies widely depending on the study design and purpose. Some trials last just a few weeks, while others may continue for months or years. The study coordinator will provide specific timeline information during your screening call.
Data: ClinicalTrials.gov · synced Sep 4, 2026 · Source of record for eligibility and locations